Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement: Prospective, Multi-center, Open-label, Randomized, Controlled, Investigator-Initiated Trial
Conditions
Interventions
Cardea SOLO
12 Lead EKG
Locations
1
South Korea
BumJoon Kim
Seoul, South Korea
Start Date
November 1, 2022
Primary Completion Date
September 13, 2024
Completion Date
September 13, 2024
Last Updated
December 15, 2025
NCT05044208
NCT03609437
NCT04604015
NCT03712865
NCT05089435
NCT03107637
Lead Sponsor
Asan Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions